The present invention describes novel compounds of Formula I which inhibit HIV integrase. The invention also describes compositions and treatments of AIDS or ARC by using these compounds.
1
New amino-alkyl-amide derivatives as CCR3 receptor ligands
申请人:PAPPNE BEHR Agnes
公开号:US20080280961A1
公开(公告)日:2008-11-13
The invention relates to a compound of the general formula (I),
as defined herein which is useful for the treatment of a pathology in a patient wherein a CCR3 receptor plays a role in the development of the pathology, and pharmaceutical preparations containing such compound.
The invention is also directed to a process for preparing the compound of the general formula (I), and intermediate useful in the preparation.